S. Sharma, P. Gajowniczek, I. Way, D. Lee, J. Jiang et al., A common signaling cascade may underlie ???addiction??? to the Src, BCR-ABL, and EGF receptor oncogenes, Cancer Cell, vol.10, issue.5, pp.425-460, 2006.
DOI : 10.1016/j.ccr.2006.09.014

C. Thibert, M. Teillet, F. Lapointe, L. Mazelin, L. Douarin et al., Inhibition of Neuroepithelial Patched-Induced Apoptosis by Sonic Hedgehog, Science, vol.301, issue.5634, pp.843-849, 2003.
DOI : 10.1126/science.1085405

E. Matsunaga, S. Tauszig-delamasure, P. Monnier, B. Mueller, S. Strittmatter et al., RGM and its receptor neogenin regulate neuronal survival, Nature Cell Biology, vol.120, issue.8, pp.749-55, 2004.
DOI : 10.1002/cne.10068

URL : https://hal.archives-ouvertes.fr/hal-00080594

M. Bordeaux, C. Forcet, L. Granger, V. Corset, C. Bidaud et al., The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease, The EMBO Journal, vol.18, issue.15, pp.4056-63, 2000.
DOI : 10.1093/emboj/19.15.4056

P. Edery, S. Lyonnet, L. Mulligan, A. Pelet, E. Dow et al., Mutations of the RET proto-oncogene in Hirschsprung's disease, Nature, vol.367, issue.6461, pp.378-80, 1994.
DOI : 10.1038/367378a0

G. Romeo, P. Ronchetto, Y. Luo, V. Barone, M. Seri et al., Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease, Nature, vol.367, issue.6461, pp.377-385, 1994.
DOI : 10.1038/367377a0

L. Mulligan, J. Kwok, C. Healey, M. Elsdon, C. Eng et al., Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A, Nature, vol.363, issue.6428, pp.458-60, 1993.
DOI : 10.1038/363458a0

M. Santoro, F. Carlomagno, A. Romano, D. Bottaro, N. Dathan et al., Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B, Science, vol.267, issue.5196, pp.381-384, 1995.
DOI : 10.1126/science.7824936

L. Mazelin, A. Bernet, C. Bonod-bidaud, L. Pays, S. Arnaud et al., Netrin-1 controls colorectal tumorigenesis by regulating apoptosis, Nature, vol.91, issue.7004, pp.80-84, 2004.
DOI : 10.1038/ncb943

URL : https://hal.archives-ouvertes.fr/hal-00314490

N. Zhang, T. Deuel, G. Stoica, A. Kuo, A. Aigner et al., Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin???binding growth and differentiation factors, Current Opinion in Hematology, vol.6, issue.1, pp.44-5016772, 1999.
DOI : 10.1097/00062752-199901000-00008

G. Stoica, A. Kuo, C. Powers, E. Bowden, E. Sale et al., Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types, Journal of Biological Chemistry, vol.277, issue.39, pp.35990-35998, 2002.
DOI : 10.1074/jbc.M205749200

W. Dirks, S. Fahnrich, Y. Lis, E. Becker, R. Macleod et al., ) gene in tumor cell lines, International Journal of Cancer, vol.20, issue.1
DOI : 10.1002/ijc.10435

C. Moog-lutz, J. Degoutin, J. Gouzi, Y. Frobert, . Brunet-de et al., Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin, Journal of Biological Chemistry, vol.280, issue.28, pp.26039-26087, 2005.
DOI : 10.1074/jbc.M501972200

A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, and T. Yamamoto, ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth, Journal of Cell Science, vol.117, issue.15, pp.3319-3348, 2004.
DOI : 10.1242/jcs.01183

URL : http://jcs.biologists.org/cgi/content/short/117/15/3319

H. Lee, A. Norris, J. Weiss, and M. Frasch, Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers, Nature, vol.425, issue.6957, pp.507-519, 2003.
DOI : 10.1038/nature01916

C. Stute, K. Schimmelpfeng, R. Renkawitz-pohl, R. Palmer, and A. Holz, Myoblast determination in the somatic and visceral mesoderm depends on Notch signalling as well as on milliways(miliAlk) as receptor for Jeb signalling, Development, vol.131, issue.4, pp.743-54, 2004.
DOI : 10.1242/dev.00972

C. Loren, A. Scully, C. Grabbe, P. Edeen, J. Thomas et al., Identification and characterization of DAlk: a novel Drosophila melanogaster RTK which drives ERK activation in vivo, Genes to Cells, vol.90, issue.6, pp.531-575, 2001.
DOI : 10.1146/annurev.biochem.57.1.443

E. Bazigou, H. Apitz, J. Johansson, C. Loren, E. Hirst et al., Anterograde Jelly belly and Alk Receptor Tyrosine Kinase Signaling Mediates Retinal Axon Targeting in Drosophila, Cell, vol.128, issue.5, pp.961-75, 2007.
DOI : 10.1016/j.cell.2007.02.024

E. Liao, W. Hung, B. Abrams, and M. Zhen, An SCF-like ubiquitin ligase complex that controls presynaptic differentiation, Nature, vol.127, issue.6997, pp.345-50, 2004.
DOI : 10.1126/science.1082475

J. Schlessinger, D. Green, and G. Evan, Cell signaling by receptor tyrosine kinases A matter of life and death, Cell Cancer Cell, vol.103, issue.1, pp.211-2519, 2000.

J. Reed, K. Doctor, and A. Godzik, The Domains of Apoptosis: A Genomics Perspective, Science Signaling, vol.2004, issue.239
DOI : 10.1126/stke.2392004re9

S. Riedl and G. Salvesen, The apoptosome: signalling platform of cell death, Nature Reviews Molecular Cell Biology, vol.156, issue.5, pp.405-418, 2007.
DOI : 10.1038/nrm2153

R. Gascoyne, L. Lamant, J. Martin-subero, V. Lestou, N. Harris et al., ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases, Blood, vol.102, issue.7, pp.2568-73, 2003.
DOI : 10.1182/blood-2003-03-0786

C. Sultan, M. Allouche, E. Campo, G. Delsol, and C. Touriol, Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells, Oncogene, vol.23, pp.6071-82, 2004.

L. Lamant, K. Pulford, D. Bischof, S. Morris, D. Mason et al., Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma, The American Journal of Pathology, vol.156, issue.5, pp.1711-1732, 2000.
DOI : 10.1016/S0002-9440(10)65042-0

A. Evans, D. Angio, G. Randolph, J. Nakamura, Y. Ikeda et al., A proposed staging for children with neuroblastoma. Children's cancer study group A High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas, Cancer Cancer Res, vol.27, issue.57, pp.374-84578, 1971.

C. Powers, A. Aigner, G. Stoica, K. Mcdonnell, and A. Wellstein, Pleiotrophin Signaling through Anaplastic Lymphoma Kinase Is Rate-limiting for Glioblastoma Growth, Journal of Biological Chemistry, vol.277, issue.16, pp.14153-14161, 2002.
DOI : 10.1074/jbc.M112354200

W. Wan, M. Albom, L. Lu, M. Quail, N. Becknell et al., Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells, Blood, vol.107, issue.4, pp.1617-1640, 2006.
DOI : 10.1182/blood-2005-08-3254